SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 29.77+3.7%Nov 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: musicman who wrote (5070)5/23/1999 9:21:00 PM
From: Mad2  Read Replies (1) of 5736
 
Musicman
How about some substance to go with your opinion. How large is the market for BiliTest, who will buy it and why? Specifically why would hospitals us it, they allready take blood samples from newborns. If the bilitest costs about the same and isn't as accurate then why use it.
As far as infants go, pediatricians can tell by looking at a infant if the child is jaundiced, at least with anglo infants. Can you cite health studies that support the usage of this device (ie how would infant care be improved with the bilitest?).
Given the supposed price of the bilitest machine (3,000-5,000) it seems they will have to sell a lot of machines to justify the existing market cap.
I think you'll admit that despite CCSI's indication that they were going to begin shipping in Feburary, the revenue they booked in the 1st quarter would permit you to count the machines they sold on one hand (if they sold any at all).
You state I for one, believe that CCSI has a viable
product and that its supporters will be rewarded with a higher stock
price.
Please provide some rational for this opinion other than opinion
Mad2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext